Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEB2 days ago · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for the companies’ Omicron KP.2-adapted monovalent COVID-19 vaccine (COMIRNATY ® KP.2) for active ...
Newsroom - Pfizer
WEB5 days ago · Updates and Statements. Pfizer Statement on Publication of ELIQUIS® Maximum Fair Price. Pfizer Receives Positive CHMP Opinion for its One-Time Gene Therapy for Adults with Hemophilia B. View All Updates and Statements.
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab …
WEBSep 14, 2024 · NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its primary endpoint of change from baseline in body weight compared to placebo in people with cancer cachexia and elevated levels of GDF-15. Cachexia is a common, life-threatening wasting condition that can ...
Pfizer’s gene therapy for rare genetic bleeding disorder ... - CNBC
WEBJul 24, 2024 · Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for ...
Pfizer rolls out another cost-cutting program, sets $1.5 billion …
WEBMay 22, 2024 · U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last...
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
WEBAug 23, 2021 · Full federal approval for the Pfizer-BioNTech coronavirus vaccine for those 16 and older is opening the way for institutions like the military, corporate employers, hospitals and school...
The FDA just approved the new Covid vaccine: When to get it ... - NBC News
WEBAug 22, 2024 · Pfizer, Moderna and Novavax are charging up to $150 per dose for a Covid vaccine, according to data from the Centers for Medicare and Medicaid Services.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBDec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
FDA Approves First COVID-19 Vaccine
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
- Some results have been removed
Skip to content